REGENXBIO, Inc. (RGNX)
7.41
+0.17
(+2.35%)
USD |
NASDAQ |
Oct 29, 16:00
7.32
-0.09
(-1.21%)
After-Hours: 06:46
REGENXBIO Price : 7.41 for Oct. 29, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | 7.36 | 7.63 | 7.21 | 7.41 | 1.036M |
| Oct 28, 2026 | 6.52 | 7.285 | 6.505 | 7.24 | 2.000M |
| Oct 27, 2026 | 6.54 | 6.78 | 6.459 | 6.60 | 1.225M |
| Oct 26, 2026 | 6.74 | 6.89 | 6.48 | 6.58 | 1.138M |
| Oct 23, 2026 | 7.03 | 7.08 | 6.628 | 6.68 | 1.452M |
| Oct 22, 2026 | 7.11 | 7.305 | 6.98 | 7.17 | 1.133M |
| Oct 21, 2026 | 7.42 | 7.47 | 7.15 | 7.17 | 945330.0 |
| Oct 20, 2026 | 7.15 | 7.58 | 7.06 | 7.40 | 1.316M |
| Oct 19, 2026 | 6.98 | 7.265 | 6.95 | 7.15 | 1.298M |
| Oct 16, 2026 | 7.14 | 7.18 | 6.875 | 6.925 | 1.210M |
| Oct 15, 2026 | 6.88 | 7.28 | 6.83 | 7.16 | 1.229M |
| Oct 14, 2026 | 7.12 | 7.24 | 6.80 | 6.88 | 1.567M |
| Oct 13, 2026 | 7.66 | 7.72 | 7.11 | 7.26 | 1.379M |
| Oct 12, 2026 | 8.12 | 8.29 | 7.74 | 7.77 | 2.034M |
| Oct 09, 2026 | 8.03 | 8.275 | 7.95 | 8.07 | 859287.0 |
| Oct 08, 2026 | 7.50 | 8.31 | 7.44 | 8.09 | 2.259M |
| Oct 07, 2026 | 7.31 | 7.73 | 7.20 | 7.595 | 1.005M |
| Oct 06, 2026 | 7.79 | 7.84 | 7.33 | 7.45 | 1.164M |
| Oct 05, 2026 | 7.80 | 8.16 | 7.57 | 7.76 | 2.354M |
| Oct 02, 2026 | 7.58 | 7.62 | 7.36 | 7.43 | 1.037M |
| Oct 01, 2026 | 7.52 | 7.736 | 7.30 | 7.42 | 1.705M |
| Sep 30, 2026 | 7.49 | 7.86 | 7.35 | 7.53 | 1.789M |
| Sep 29, 2026 | 7.41 | 7.64 | 7.33 | 7.45 | 2.096M |
| Sep 28, 2026 | 7.30 | 7.495 | 7.170 | 7.47 | 1.326M |
| Sep 25, 2026 | 7.53 | 7.675 | 7.165 | 7.40 | 1.277M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 290.79 |
| United Therapeutics Corp. | 593.54 |
| Biomea Fusion, Inc. | 0.6228 |
| RenovoRx, Inc. | 1.49 |
| ACADIA Pharmaceuticals, Inc. | 20.76 |
Price Related Metrics
| PS Ratio | 2.218 |
| PEG Ratio | -0.2116 |
| Price to Book Value | 5.593 |
| Earnings Yield | -51.08% |
| Market Cap | 401.36M |
| PEGY Ratio | -0.2116 |